Literature DB >> 1015352

A case report including EM and DNA repair investigations in a dermatosis associated with multiple skin cancers: epidermodysplasia verruciformis.

H Hammar, L Hammar, L Lambert, U Ringborg.   

Abstract

This report describes the clinical, histological and electron microscopic observations in a 51-year-old male with epidermodysplasia veruciformis (EV). Cells with early signs of malignant transformation were found closely connected with virus infected epidermal regions. Skin cancers appeared initially on sun-exposed areas, such as the face and ear lobes. The UV-induced DNA repair synthesis was therefore studied, utilizing peripheral leukocytes. The patient had 40% lower UV-induced DNA repair synthesis than the mean of nine healthy subjects of the same age. These results suggest that a decrease in UV-induced DNA repair synthesis in combination with a possibly oncogenic viral infection may enhance the disposition for somatic mutations and malignant transformation in patients with EV.

Entities:  

Mesh:

Year:  1976        PMID: 1015352     DOI: 10.1111/j.0954-6820.1976.tb08261.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  3 in total

1.  Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis.

Authors:  G Orth; S Jablonska; M Favre; O Croissant; M Jarzabek-Chorzelska; G Rzesa
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Epidermodysplasia verruciformis. Clinical and light- and electron-microscopic observations during etretinate therapy.

Authors:  L O Kanerva; E Johansson; K M Niemi; J Lauharanta; O P Salo
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Human papillomaviruses associated with epidermodysplasia verruciformis. II. Molecular cloning and biochemical characterization of human papillomavirus 3a, 8, 10, and 12 genomes.

Authors:  D Kremsdorf; S Jablonska; M Favre; G Orth
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.